Over the past year, many dividend stocks lost their luster for two reasons. First, higher-growth AI stocks continuously pulled investors away from conservative income stocks. Second, the Fed's rate hike in September -- its first in three years -- drove up the yields of safer fixed-income investments and made them more attractive than blue chip dividend stocks. That pressure might persist through the end of the year, but it's creating attractive buying opportunities for income investors who plan to hold their dividend stocks for the long term. Let's look at three dividend stocks that are worth buying with $5,000 (or more) in November: AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Medtronic (NYSE: MDT). Image source: Getty Images.
CryptoAlerta — análise de criptomoedas e mercado em tempo real